|
ABOUT COMPANY
Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United States. The company is headquartered in Dublin, Ireland.
|
EARNINGS
Gross Profit (TTM): 482616000
Market Capitalization: 1333934000
Operating Margin (TTM): 0.0258
PE Ratio: None
PEG Ratio: -1.74
Profit Margin: -0.0034
Revenue Per Share (TTM): 1.536
Revenue (TTM): 605947000
Quarterly Earnings Growth YOY: 0.972
Quarterly Revenue Growth YOY: -0.092
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.011
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: 18229000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|